Cargando…

Correction to: Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression

Detalles Bibliográficos
Autores principales:	Liu, Zhikui, Mo, Huanye, Liu, Runkun, Niu, Yongshen, Chen, Tianxiang, Xu, Qiuran, Tu, Kangsheng, Yang, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799674/ https://www.ncbi.nlm.nih.gov/pubmed/35091557 http://dx.doi.org/10.1038/s41419-022-04528-y

Ejemplares similares

Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression
por: Liu, Zhikui, et al.
Publicado: (2021)

Long noncoding RNA PICSAR/miR‐588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway
por: Liu, Zhikui, et al.
Publicado: (2020)

CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway
por: Yang, Nan, et al.
Publicado: (2020)

MicroRNA-875-5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a
por: Chen, Tianxiang, et al.
Publicado: (2020)

Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression
por: Wang, Liang, et al.
Publicado: (2021)

Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression
por: Wang, Jun, et al.
Publicado: (2021)

Long noncoding RNA FIRRE contributes to the proliferation and glycolysis of hepatocellular carcinoma cells by enhancing PFKFB4 expression
por: Shen, Cunyi, et al.
Publicado: (2021)

HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway
por: Chen, Tianxiang, et al.
Publicado: (2021)

Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2019)

Retraction Note: Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2022)

FOXC2-AS1/FOXC2 axis mediates matrix stiffness-induced trans-differentiation of hepatic stellate cells into fibrosis-promoting myofibroblasts
por: Sun, Liankang, et al.
Publicado: (2023)

Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP
por: Sun, Liankang, et al.
Publicado: (2019)

LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells
por: Sun, Liankang, et al.
Publicado: (2020)

Deubiquitinase PSMD7 promotes the proliferation, invasion, and cisplatin resistance of gastric cancer cells by stabilizing RAD23B
por: Wang, Jianjiang, et al.
Publicado: (2021)

Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma
por: Tu, Kangsheng, et al.
Publicado: (2021)

ZNF521 which is downregulated by miR-802 suppresses malignant progression of Hepatocellular Carcinoma through regulating Runx2 expression
por: Yang, Nan, et al.
Publicado: (2020)

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418
por: Wang, Liang, et al.
Publicado: (2019)

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction
por: Wang, Liang, et al.
Publicado: (2022)

High-matrix-stiffness induces promotion of hepatocellular carcinoma proliferation and suppression of apoptosis via miR-3682-3p-PHLDA1-FAS pathway
por: Yao, Bowen, et al.
Publicado: (2020)

A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma
por: Li, Yue, et al.
Publicado: (2022)

PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-β receptor I versus II
por: Sun, Liankang, et al.
Publicado: (2022)

Hypoxia‐induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway
por: Yao, Bowen, et al.
Publicado: (2021)

Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts
por: Kawada, Norifumi
Publicado: (2015)

Extracellular Matrix Stiffness and Composition Regulate the Myofibroblast Differentiation of Vaginal Fibroblasts
por: Ruiz-Zapata, Alejandra M., et al.
Publicado: (2020)

Matrix stiffness and architecture drive fibro-adipogenic progenitors’ activation into myofibroblasts
por: Loomis, Taryn, et al.
Publicado: (2022)

MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway
por: Xu, Qiuran, et al.
Publicado: (2017)

MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2018)

Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2022)

Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma
por: Li, Yue, et al.
Publicado: (2022)

Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis
por: Lachowski, Dariusz, et al.
Publicado: (2019)

Single‐Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell–Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice
por: Yang, Wu, et al.
Publicado: (2021)

Morphological characterisation of portal myofibroblasts and hepatic stellate cells in the normal dog liver
por: IJzer, Jooske, et al.
Publicado: (2006)

Extracellular matrix stiffness controls cardiac valve myofibroblast activation through epigenetic remodeling
por: Walker, Cierra J., et al.
Publicado: (2022)

A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection
por: Wang, Huanhuan, et al.
Publicado: (2023)

p300 Acetyltransferase Is a Cytoplasm‐to‐Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β–Stimulated Hepatic Stellate Cells
por: Wang, Yuanguo, et al.
Publicado: (2019)

Stiffening hydrogels for investigating the dynamics of hepatic stellate cell mechanotransduction during myofibroblast activation
por: Caliari, Steven R., et al.
Publicado: (2016)

The Dual-Mode Transition of Myofibroblasts Derived from Hepatic Stellate Cells in Liver Fibrosis
por: Yan, Mengchao, et al.
Publicado: (2023)

HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2017)

Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma
por: Wang, Yufeng, et al.
Publicado: (2018)

Correction: Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma
por: Wang, Yufeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_npoe7bt9rak82phsbqesseq68j